4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-417919
Chief Executive Officer sold 4,522 shares at an average $31.68 ($143,273)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ceesay Abraham · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-10-06 | Sale : show line 1 in the form 10b5-1 | −3,375 | $32.03 | $108,106 | 453,392 | D |
| 2026-10-07 | Sale : show line 2 in the form 10b5-1 | −1,147 | $30.66 | $35,167 | 452,245 | D |
| Open-market sales · 4,522 sh · avg $31.68 · $143,273 | ||||||
Loading xslF345X06/ownership.xml…